5-hydroxydecanoate has been researched along with nad in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camara, AK; Chen, Q; Eells, JT; Novalija, E; Riess, ML; Stowe, DF | 1 |
| Banaszak, LJ; Banerjee, AL; Barycki, JJ; Brandt, U; Daut, J; Dröse, S; Hanley, PJ; Lareau, RA; Srivastava, DK; Van Veldhoven, PP | 1 |
2 other study(ies) available for 5-hydroxydecanoate and nad
| Article | Year |
|---|---|
Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: reversal by 5-hydroxydecanoic acid.
Topics: Anesthetics, Inhalation; Animals; ATP-Binding Cassette Transporters; Blood Pressure; Coronary Circulation; Decanoic Acids; Fluorescence; Guinea Pigs; Heart; Hydroxy Acids; In Vitro Techniques; Ischemic Preconditioning, Myocardial; KATP Channels; Male; Methyl Ethers; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; NAD; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Sevoflurane; Ventricular Function, Left | 2003 |
5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids.
Topics: Animals; Biotransformation; Coenzyme A; Decanoic Acids; Esters; Fatty Acids; Hydroxy Acids; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Kinetics; Mitochondria; Mitochondria, Heart; Mitochondria, Liver; Models, Molecular; NAD; Oxidation-Reduction; Rats | 2005 |